BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease

Cancer Research

Volumn 58, Issue 7, 1998, Pages 1367-1371

  Haraldsson, Karin ^a   Loman, Niklas ^a   Zhang, Qiu Xia ^a   Johannsson, Oskar ^a   Olsson, Håkan ^a   Borg, Åke ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GERM LINE; HUMAN; HUMAN TISSUE; MALE; MUTATION RATE; PRIORITY JOURNAL; SWEDEN; TUMOR SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; BRCA2 PROTEIN; BREAST NEOPLASMS, MALE; DNA, NEOPLASM; FAMILY HEALTH; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTORS, ANDROGEN; TRANSCRIPTION FACTORS;

EID: 0032053728     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Szabo, C. I., and King, M-C. Inherited breast and ovarian cancer. Hum. Mol. Genet., 4: 1811-1817, 1995.
2. Stratton, M. R. Recent advances in understanding of genetic susceptibility to breast cancer. Hum. Mol. Genet., 5: 1515-1519, 1996.
3. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugenstrano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb A., and Skolnick, M. H. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (Washington DC), 266: 66-71, 1994.
4. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., Barfoot, R., Hamoudi, R., Patel, S., Rice, C., Biggs, P., Hashim, Y., Smith, A., Conner, F., Arason, A., Gudmundsson, J., Ficenec, D., Kelsell, D., Ford, D., Tonin, P., Bishop, D. T., Spurr, N. K., Ponder, B. A. J., Eeles, R., Peto, J., Devilee, P., Cornelisse, C., Lynch, H., Narod, S., Lenoir, G., Egilsson, V., Barkadottir, R. B., Easton, D. F., Bentley, D. R., Futreal, P. A., Ashworth, A., and Stratton, M. R. Identification of the breast cancers susceptibility gene BRCA2. Nature (Lond.), 378: 789-792, 1995.
5. Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., Belanger, C., Bell, R., Berry, S., Bogden, R., Chen, Q., Davis, T., Dumont, M., F., Mitchell, J. T., McArthur-Morrison, J., Nguyen, K., Peng, Y., Samson, C., Schroeder, M., Snyder, S. C., Steele, L., Stringfellow, M., Stroup, C., Swedlund, Feldhouse, J., Wong, A. K. C., Shizuya, H., Eyfjörd, J. E., Cannon-Albright, L., Labrie, F., Skolnick, M. H., Weber, B., Kamb, A., and Goldgar, D. E. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet., 12: 333-337, 1996.
6. Szabo, C., and King, M-C. Population genetics of BRCA1 and BRCA2. Am. J. Hum. Genet., 60: 1013-1030, 1997.
7. Crichlow, R. W., and Galt, S. W. Male breast cancer. Surg. Clin. North Am., 70: 1165-1177, 1990.
8. Donegan, W. L., and Redlich, P. N. Breast cancer in men. Surg. Clin. North Am., 76: 343-363, 1996.
9. Sasco, A. J., Lowenfels, A. B., and Pasker de Jong, P. Review article: epidemiology of male breast cancer: a meta-analysis of published case-control studies and discussion of selected aetiological factors. Int. J. Cancer, 53: 538-549, 1993.
10. Hecht, J. R., and Winchester, D. J. Male breast cancer. Am. J. Clin. Pathol., 102: S25-S30, 1994.
11. Wooster, R., Mangion, J., Eeles, R., Smith, S., Dowsett, M., Averill, D., Barrett Lee, P., Easton, D. F., Ponder, B. A., and Stratton, M. R. A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat. Genet., 2: 132-134, 1992.
12. Lobaccaro, J. M., Lumbroso, S., Belon, C., Galtier Dereure, F., Bringer, J., Lesimple, T., Namer, M., Cutuli, B. F., Pujol, H., and Sultan, C. Androgen receptor gene mutation in male breast cancer. Hum. Mol. Genet., 2: 1799-1802, 1993.
13. Moore, M. P. Male breast cancer. In: J. R. Harris, M. E. Lippman, M. Morrow, S. Hellman (eds.), Diseases of the Breast, pp. 859-863. Philadelphia: Lippincott-Raven Publishers, 1996.
14. Thorlacius, S., Olafsdottir, G., Tryggvadottir, L., Neuhausen, S., Jonasson, J. G., Tavtigian, S. V., Tulinius, H., Ögmundsdottir, H. M., and Eyfjörd, J. E. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat. Genet., 13: 117-119, 1996.
15. Couch, F. J., Fand, L. M., DeShano, M. L., Tavtigian, S. V., Calzone, K., Campeau, L., Peng, Y., Bogden, B., Chen, Q., Neuhausen, S., Shattuck-Eidens, D., Godwin, A. K., Daly, M., Radford, D. M., Sedlacek, S., Rommens, J., Simard, J., Garber, J., Merajver, S., and Weber, B. L. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat. Genet., 13: 123-125, 1996.
16. Friedman, L. S., Gayther, S. A., Kurosaki, T., Gordon, D., Noble, B., Casey, G., Ponder, B. A., and Anton-Culver, H. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am. J. Hum. Genet., 60: 313-319, 1997.
17. Håkansson, S., Johansson, J., Johansson, U., Sellberg, G., Loman, N., Gerdes, A-M., Holmberg, E., Dahl, N., Kristofferson, U., Olsson, H., and Borg, Å. Moderate frequency of BRCA1 and BRCA2 germline mutations in Scandinavian familial breast cancer. Am. J. Hum. Genet., 60: 1068-1078, 1997.
18. Wong, A. K. C., Pero, R., Ormonde, P. A., Tavtigian, S. V., and Bartel, P. L. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J. Biol. Chem., 272: 31941-31944, 1997.
19. Gayther, S., Mangion, J., Russell, P., Seal, S., Barfoot, R., Ponder, B. A. J., Stratton, M. R., and Easton, D. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat. Genet., 15: 103-105, 1997.
20. Ramus, S. J., Kote-Jarai, Z., Friedman, L. S., van der Looij, M., Gayther, S. A., Csokay, B., Ponder, B. A. J., and Olah, E. Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer. Am. J. Hum. Genet., 60: 1242-1246, 1997.
21. Mazoyer, S., Dunning, A. M., Serova, O., Dearden, J., Puget, N., Healey, C. S., Gayther, S. A., Mangion, J., Stratton, M. R., Lynch, H. T., Goldgar, D. E., Ponder, B. A. J., and Lenoir, G. M. A polymorphic stop codon in BRCA2. Nat. Genet., 14: 253-254, 1996.
22. Roa, B. B., Boyd, A. A., Volcik, K., and Richards, C. S. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat. Genet., 14: 185-187, 1996.
23. Oddoux, C., Struewing, J. P., Clayton, C. M., Neuhausen, S., Brody, L. C., Kaback, M., Haas, B., Norton, L., Borgem, P., Jhanwar, S., Goldgar, D., Ostrer, H., and Offit, K. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat. Genet., 14: 188-190, 1996.
24. Narod, S. A., Goldgar, D., Cannon-Albright, L., Weber, B., Moslehi, R., Ives, E., Lenoir, G., and Lenoir, H. Risk modifiers in carriers of BRCA1 mutations. Int. J. Cancer, 64: 394-398, 1995.
25. Phelan, C. M., Rebbeck, T. R., Weber, B. L., Devilee, P., Ruttledge, M. H., Lynch, H. T., Lenoir, G. M., Stratton, M. R., Easton, D. F., Ponder, B. A., Cannon Albright, L., Larsson, C., Goldgar, D. E., and Narod, S. A. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nat. Genet., 12: 309-311, 1996.
26. Brinkmann, A. O., Jenster, G., Ris Stalpers, C., van der Korput, J. A., Bruggenwirth, H. T., Boehmer, A. L., and Trapman, J. Androgen receptor mutations. J. Steroid Biochem. Mol. Biol., 53: 443-448, 1995.
27. Choong, C. S., Kemppainen, J. A., Zhou, Z., and Wilson, E. M. Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol. Endocrinol., 10: 1527-1535, 1996.
28. Chamberlain, N. L., Driver, E. D., and Miesfeld, R. L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res., 22: 3181-3186, 1994.
29. Ingles, S. A., Ross, R. K., Yu, M. C., Irvine, R. A., La Pera, G., Haile, R. W., and Coetzee, G. A. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J. Natl. Cancer Inst., 89: 166-170, 1997.